Evidence map›Paper›PMID 25867763›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2015

Phenotypic diversity of patient-derived melanoma populations in stem cell medium.

Malgorzata Sztiller-Sikorska, Mariusz L Hartman, Beata Talar, Justyna Jakubowska, Izabela Zalesna, Malgorzata Czyz

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Pmel17 Deficiency Affects Melanogenesis and Promotes Tumor Vascularization.International journal of molecular sciences · 2026
    Article
  5. Article
  6. Impact of Rab27 on Melanoma Cell Invasion and sEV Secretion.International journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Physiologically Relevant Oxygen Concentration (6% OInternational journal of molecular sciences · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Vemurafenib and trametinib reduce expression of CTGF and IL-8 inLaboratory investigation; a journal of technical methods and pathology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Malgorzata Sztiller-SikorskaDepartment of Molecular Biology of Cancer, Medical University of Lodz, Lodz, Poland.
Mariusz L HartmanDepartment of Molecular Biology of Cancer, Medical University of Lodz, Lodz, Poland.
Beata TalarDepartment of Molecular Biology of Cancer, Medical University of Lodz, Lodz, Poland.
Justyna JakubowskaDepartment of Molecular Biology of Cancer, Medical University of Lodz, Lodz, Poland.
Izabela ZalesnaDepartment of Molecular Biology of Cancer, Medical University of Lodz, Lodz, Poland.
Malgorzata CzyzDepartment of Molecular Biology of Cancer, Medical University of Lodz, Lodz, Poland.
Medical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanomas are highly heterogeneous tumors and there is no treatment effective at achieving long-term remission for metastatic melanoma patients. Thus, an appropriate model system for studying melanoma biology and response to drugs is necessary. It has been shown that composition of the medium is a critical factor in preserving the complexity of the tumor in in vitro settings, and melanospheres maintained in stem cell medium are a good model in this respect. In the present study, we observed that not all nodular melanoma patient-derived cell populations grown in stem cell medium were capable of forming melanospheres, and cell aggregates and anchorage-independent single-cell cultures emerged instead. Self-renewing capacity and unlimited growth potential indicated the presence of cells with stem-like properties in all patient-derived populations but immunophenotype and MITF expression exhibited variability. Enhanced MITF expression and activity was observed in melanospheres in comparison with cell aggregates and single-cell culture, and hypoxic-like conditions that increased the ability of single-cell population to form melanospheres enhanced MITF expression and cell pigmentation as well. Thus, MITF seems to be a critical transcription factor for formation of both patient-derived and hypoxia-induced melanospheres. After 2 years of continuous culturing, melanospheres progressively underwent transition into cell aggregates that was accompanied by changes in expression of several MITF-dependent genes associated with melanogenesis and survival and alterations in the composition of subpopulations but not in the frequency of ABCB5-positive cells. Several biological properties of parent tumor are well preserved in patient-derived melanospheres, but during prolonged culturing the heterogeneity is substantially lost when the melanospheres are substituted by cell aggregates. This should be considered when cell aggregates instead of melanospheres are used in the study of melanoma biology and cell response to drugs.

Indexed as

AC133 AntigenAntigens, CDCell Culture TechniquesCell HypoxiaCulture MediaGlycoproteinsHumansMelanomaMicrophthalmia-Associated Transcription FactorMonophenol MonooxygenaseNeoplastic Stem CellsPeptidesSpheroids, CellularTumor Cells, CulturedAC133 AntigenAntigens, CDCulture MediaGlycoproteinsMicrophthalmia-Associated Transcription FactorMITF protein, humanMonophenol MonooxygenasePeptides

Identifiers

PMID25867763
OpenAlexW2114639673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.